Master data| INID | Criterion | Field | Content |
|---|
| Type of IP right | SART | Protection certificate |
| Status | ST | Pending/in force |
| 21 | DE file number | DAKZ | 12 2017 000 018.0 |
| Use | VZ | Medicinal products |
| 95 | Product name | TIEZ | Vedolizumab |
| 54 | Title of basic patent | TIGZ | Antikörper gegen Alpha4beta7 Integrin und sein Verwendung zur Behandlung von Darmerkrankungen |
| 51 | IPC main class | ICM
(ICMV) | A61K 39/395 (2006.01) |
| 51 | IPC secondary class(es) | ICS
(ICSV) | A61K 31/635 (2006.01), A61K 31/60 (2006.01), A61K 31/57 (2006.01), A61K 31/52 (2006.01), A61P 37/06 (2006.01) |
| 94 | Start of term of protection | LB | Apr 14, 2021 |
| 94 | End of term of protection | LE | Apr 13, 2026 |
| 22 | DE application date | DAT | Apr 12, 2017 |
| Date of publication of application for a certificate | OT | Jul 6, 2017 |
| Date of publication of grant of certificate | PET | Aug 12, 2021 |
| 71/73 | Applicant/owner | INH | Genentech, Inc., 1 DNA Way, South San Francisco, CA, US; Takeda Pharmaceutical Co. Ltd., 1-1, Doshomachi 4-chome, 541-0045 Osaka, JP |
| 74 | Representative | VTR | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Address for service | | HOFFMANN-EITLE Patent- und Rechtsanwälte PartmbB, 81925 München, DE |
| Patent division in charge | | 44 |
| 68 | DE file number of basic patent | GAKZ | 601 50 161.6 |
| 68 | EP file number of basic patent | GEAKZ | 10 01 0997.4 |
| 43 | Date of first publication | EVT | Jul 6, 2017 |
92
92
92
| Domestic authorisation | GIS
GIN
GIT
| Europäische Kommission
EU/1/14/923
2014-05-22
|
93
93
93
93
| EU authorisation | GES
GEC
GEN
GET
| Europäische Kommission
EU
EU/1/14/923
2014-05-22
|
| Date of the first transfer into DPMAregister | EREGT | Jul 6, 2017 |
| Date of the (most recent) update in DPMAregister | REGT | May 7, 2025
(Show all update days)(Hide all update days)- May 7, 2025
- Nov 12, 2024
- Aug 5, 2024
- St.36: changed (technical change)
- Apr 23, 2024; Apr 25, 2023; May 5, 2022; Aug 12, 2021; Jul 6, 2021; Jul 4, 2021; Apr 29, 2021; Mar 26, 2021; Jul 16, 2019; May 23, 2019
- Historical data not available for this/these date(s)
- Jul 6, 2017
- Date of the first transfer into DPMAregister
|
View procedures New applicant/owner details (No.: 2)| INID | Criterion | Field | Content
Close details
|
|---|
| Type of procedure | VART | New applicant/owner details |
| Legal/procedural status | VST | New applicant/owner details |
| Date of legal/procedural status | VSTT | Mar 25, 2021 |
| 71/73 | Applicant/owner | INH | Genentech, Inc., South San Francisco, CA, US; Takeda Pharmaceutical Co. Ltd., 541-0045 Osaka, JP |
| 71/73 | Previous applicant/owner | INHF | Genentech, Inc., South San Francisco, Calif., US, Millennium Pharmaceuticals, Inc., Cambridge, Mass., US |
| Date of update of the procedure | REGT | Apr 29, 2021 |
